Your browser doesn't support javascript.
loading
Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom.
Dregan, Alex; McNeill, Ann; Gaughran, Fiona; Jones, Peter B; Bazley, Anna; Cross, Sean; Lillywhite, Kate; Armstrong, David; Smith, Shubulade; Osborn, David P J; Stewart, Robert; Wykes, Til; Hotopf, Matthew.
Affiliation
  • Dregan A; Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, United Kingdom.
  • McNeill A; Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, United Kingdom.
  • Gaughran F; Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, United Kingdom.
  • Jones PB; South London and Maudsley NHS Foundation Trust and London, London, United Kingdom.
  • Bazley A; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Cross S; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom.
  • Lillywhite K; South London and Maudsley NHS Foundation Trust and London, London, United Kingdom.
  • Armstrong D; South London and Maudsley NHS Foundation Trust and London, London, United Kingdom.
  • Smith S; South London and Maudsley NHS Foundation Trust and London, London, United Kingdom.
  • Osborn DPJ; School of Population Health and Environmental Sciences, King's College London, London, United Kingdom.
  • Stewart R; Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, United Kingdom.
  • Wykes T; Division of Psychiatry, Faculty of Brain Sciences, University College London, London, United Kingdom.
  • Hotopf M; Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, United Kingdom.
PLoS One ; 15(3): e0230674, 2020.
Article in En | MEDLINE | ID: mdl-32218598
ABSTRACT

BACKGROUND:

To estimate the potential gain in life expectancy from addressing modifiable risk factors for all-cause mortality (excluding suicide and deaths from accidents or violence) across specific serious mental illness (SMI) subgroups, namely schizophrenia, schizoaffective disorders, and bipolar disorders in a Western population.

METHODS:

We have used relative risks from recent meta-analyses to estimate the population attribution fraction (PAF) due to specific modifiable risk factors known to be associated with all-cause mortality within SMI. The potential gain in life expectancy at birth, age 50 and age 65 years were assessed by estimating the combined effect of modifiable risk factors from different contextual levels (behavioural, healthcare, social) and accounting for the effectiveness of existing interventions tackling these factors. Projections for annual gain in life expectancy at birth during a two-decade was estimated using the Annual Percentage Change (APC) formula. The predicted estimates were based on mortality rates for year 2014-2015.

RESULTS:

Based on the effectiveness of existing interventions targeting these modifiable risk factors, we estimated potential gain in life expectancy at birth of four (bipolar disorders), six (schizoaffective disorders), or seven years (schizophrenia). The gain in life expectancy at age 50 years was three (bipolar disorders) or five (schizophrenia and schizoaffective disorders) years. The projected gain in life expectancy at age 65 years was three (bipolar disorders) or four (schizophrenia and schizoaffective disorders) years.

CONCLUSIONS:

The implementation of existing interventions targeting modifiable risk factors could narrow the current mortality gap between the general and the SMI populations by 24% (men) to 28% (women). These projections represent ideal circumstances and without the limitation of overestimation which often comes with PAFs.
Subject(s)

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Bipolar Disorder / Life Expectancy Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: PLoS One Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Bipolar Disorder / Life Expectancy Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: PLoS One Year: 2020 Document type: Article